Biology of pediatric peripheral neuroectodermal tumors

Le Douarin N: In: The Neural Crest. Cambridge University Press, London, 1981 Cooper MJ, Hutchins GM, Israel MI: Histiogenesis of the human adrenal medulla. Am J Pathol 137(3): 605–615, 1990 Young JL, Miller RW: Incidence of malignant tumors in U.S. children. J Pediatr 86: 254–258, 1975 Hayes F, Smith E: Neuroblastoma. In: Pizzo P, Poplack D (eds) Principle and Practice of Pediatric Oncology. Lippincott, Philadelphia, 1989, pp 607–622 Bolande RP: Spontaneous regression and cytodifferentiation of cancer in early life: The oncogenic grace period. Surv Synth Path Res 4: 296–311, 1985 Beckwith JB, Perrin EV:In situ neuroblastoma: A contribution to the natural history of neural crest tumors. Am J Pathol 43: 1089–1104, 1963 Kushner B, Gilbert F, Helson L: Familial neuroblastoma. Cancer 57: 1887–1893, 1986 Knudson AJ, Strong LC: Mutation and cancer. Neuroblastoma and Pheochromocytoma. Am J Hum Genet 24: 512–532, 1972 Bader SA, Fasching C, Brodeur GM, Standbridge EJ: Dissociation of suppression of tumorigenicity and differentiationin vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth & Diff 2: 245–255, 1991 Laug W, Siegael S, Shaw K, Landing B, Baptista J, Gutenstein M: Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma. Pediatrics 62: 77–83, 1978 Hann H, Evans A, Siegel S et al.: Prognostic importance of serum ferritin in patients with Stage III and IV neuroblastoma: The CCSG experience. Cancer Res 46: 440–443, 1985 Look AT, Hayes FA, Nitschke R et al.: Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Eng J Med 311: 231–235, 1984 Schwab M, Alitalo K, Klempnauer K-H et al.: Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature 305: 245–248, 1983 Brodeur G, Seeger R, Schwab M et al.: Amplification of N-myc in untreated neuroblastoma correlates with advanced stage disease. Science 224: 1121–1124, 1984 Ewing J: Diffuse endothelioma of bone. Proc NY Pathol Soc 21: 17–24, 1921 Horowitz M, DeLaney T, Malawer Met al.: Ewing's sarcoma family of tumors: Ewing's sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. In: Pizzo P, Poplack D (eds) Principles of Pediatric Oncology. 1991, in press Askin F, Rosai J, Sibley R et al.: Malignant small cell tumor of the thoracopulmonary region in childhood. A distinct clinicopathologic entity of uncertain histogenesis. Cancer 43: 2438–2451, 1979 Kaye J, Warhol M, Kretschmar M et al.: Neuroblastoma in adults. Three case reports and a review of the literature. Cancer 58: 1149–1157, 1986 Whang-peng J, Triche T, Knutsen T: Chromosome translocation in peripheral neuroepithelioma. N Eng J Med 311: 584, 1984 Lipinski M, Braham K, Philip I et al.: Neuroectodermal associated antigens on Ewing's sarcoma cell lines. Cancer Res 47: 1983–1990, 1987 McKeon C, Thiele C, Ross R et al.: Indistinguishable patterns of proto-oncogene expression mark two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma. Cancer Res 48: 4307–4311, 1988 El-Badry O, Romanus J, Helman L et al.: Autonomous growth of a neuroblastoma cell line is mediated by insulin-like growth factor II. J Clin Invest 84: 829–839, 1989 Yee D, Favoni RE, Lebovic GS et al.: Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor. J Clin Invest 86: 1806–1814, 1990 El-Badry O, Helman L, Chatten J et al.: Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J Clin Invest 87: 648–657, 1991 Thiele CJ, McKeon C, Triche T, et al.: Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral system. J Clin Invest 80: 804–811, 1987 Rosolen A, Whitesell L, Ikegaki N et al.: Antisense inhibition of single copy N-myc expression results in decreased cell growth with reduction of c-myc protein in a neuroepithelioma cell line. Cancer Res 50: 6315–6322, 1990 Collum RG, Depinho R, Mellis S, Thiele C, Israel MA, Alt FW: A novel gene expressed specifically in neuroepitheliomas and related tumors. In: Furth M, Greaves M (eds) Cancer Cells: Molecular Diagnostics of Human Cancer. Cold Spring Harbor Laboratory Press, 1989, pp 113–116 Reynolds C, Smith G: A sensitive immunoassay for human neuroblastoma cells. In: Mitchell N, Oettgen H (eds) Hybridomas in Cancer Diagnosis and Treatment. Raven Press, New York, 1982 Donner L, Triche T, Israel M et al.: A panel of monoclonal antibodies which discriminate neuroblastoma from Ewing's sarcoma, rhabdomyosarcoma neuroepithelioma and hematopoietic malignancies. Prog Clin Biol Res 175: 347–366, 1995 Cavazzana AO, Miser JS, Jefferson, et al.: Experimental evidence for a neural origin of Ewing's sarcoma of bone. Am J Pathol 127: 507, 1987 Wexler LH, Thiele CJ: Differential growth regulation of NE and ES cell lines by IFN-gamma. Proc AACR 32: 37 (218A), 1991 Ciccarone V, Spengler B, Meyers M et al.: Phenotypic diversification in human neuroblastoma cells: Expression of neural crest lineages. Cancer Res 49: 219–225.2, 1989 Cooper M, Hutchins G, Cohen P et al.: Human neuroblastoma tumor cell lines correspond to the attested differentiation of chromaffin adrenal medullary neuroblasts. Cell Growth Diff 1: 149–158, 1990 Abemayor E, Sidell N: Human neuroblastoma cell lines a models for thein vitro study of neoplastic and neuronal differentiation. Environ Health Perspec 80: 3–15, 1989 Gaetano C, Matsumoto K, Thiele CJ: Retinoic acid resistant neuroblastoma cells and the expression of insulin-like growth factor. Adv Neuroblastoma Res 3: 165–172, 1991 Chen P, Scully D, Shew J et al.: Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58: 1193–1198, 1988 Thiele CJ, Reynolds CP, Israel MA: Decreased expression of N-myc precedes retinoic acid induced morphological differentiation of human neuroblastoma. Nature 313 (6001): 404–406, 1985 Gaetano C, Matsumoto K, Thiele C: Retinoic acid negatively regulates p34cdc2 expression during human neuroblastoma differentiation. Cell Growth Diff in press, 1991. Whitesell L, Rosolen A, Neckers LM: Episome-generated N-myc antisense RNA restricts the differentiation potential of primitive neuroectodermal cell lines. Mol Cell Biol 11: 1360–1371, 1991 Huang ME, Ye HC, Chen SR et al: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukaemia. Blood 72: 567, 1988 Castaigne S, Chomienne C, Daniel MT et al.: All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukaemia. I. Clinical results. Blood 76: 1704, 1990